Glucagon Application Scope: A Descriptive Summary of Its Medical Uses
Abstract: Glucagon, a 29-amino acid peptide hormone, is primarily indicated for severe hypoglycemia and as a diagnostic aid in gastrointestinal radiology. Its medical scope extends to beta-blocker/calcium channel blocker overdose and anaphylaxis refractory to epinephrine. The peptide market trends show a CAGR of 7.8% (2024-2030), driven by stable glucagon analogs. Brand comparison reveals Novo Nordisk’s GlucaGen® leads in purity (>99%) and stability, while generic versions offer cost advantages. Key technical parameters include reconstitution time (<1 minute) and shelf life (24 months at 2-8°C). Current industry challenges include cold-chain logistics and regulatory compliance (FDA/EMA certificates). Selection criteria prioritize potency, excipient compatibility, and manufacturer GMP certification.